Ever Source Wealth Advisors, LLC Heron Therapeutics, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 33 shares of HRTX stock, worth $53. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33Holding current value
$53% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HRTX
# of Institutions
174Shares Held
118MCall Options Held
80.4KPut Options Held
94.9K-
Rubric Capital Management LP New York, NY26.7MShares$43.3 Million1.48% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.85MShares$14.3 Million0.03% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$13.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.16MShares$13.2 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$11.3 Million28.8% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $192M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...